These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 37245517)

  • 1. The third Intensive Care Bundle with Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT3): an international, stepped wedge cluster randomised controlled trial.
    Ma L; Hu X; Song L; Chen X; Ouyang M; Billot L; Li Q; Malavera A; Li X; Muñoz-Venturelli P; de Silva A; Thang NH; Wahab KW; Pandian JD; Wasay M; Pontes-Neto OM; Abanto C; Arauz A; Shi H; Tang G; Zhu S; She X; Liu L; Sakamoto Y; You S; Han Q; Crutzen B; Cheung E; Li Y; Wang X; Chen C; Liu F; Zhao Y; Li H; Liu Y; Jiang Y; Chen L; Wu B; Liu M; Xu J; You C; Anderson CS;
    Lancet; 2023 Jul; 402(10395):27-40. PubMed ID: 37245517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. INTEnsive care bundle with blood pressure reduction in acute cerebral hemorrhage trial (INTERACT3): study protocol for a pragmatic stepped-wedge cluster-randomized controlled trial.
    Song L; Hu X; Ma L; Chen X; Ouyang M; Billot L; Li Q; Muñoz-Venturelli P; Abanto C; Pontes-Neto OM; Antonio A; Wasay M; Silva A; Thang NH; Pandian JD; Wahab KW; You C; Anderson CS;
    Trials; 2021 Dec; 22(1):943. PubMed ID: 34930428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statistical Analysis Plan for the INTEnsive Care Bundle with Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial: A Stepped-Wedge Cluster Randomized Controlled Trial.
    Billot L; Song L; Hu X; Ma L; Ouyang M; Chen X; You C; Anderson CS;
    Cerebrovasc Dis; 2023; 52(3):251-254. PubMed ID: 36063792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementing a Goal-Directed Care Bundle after Acute Intracerebral Haemorrhage: Process Evaluation for the Third INTEnsive Care Bundle with Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial Study in China.
    Ouyang M; Anderson CS; Song L; Jan S; Sun L; Cheng G; Chu H; Hu X; Ma L; Chen X; You C; Liu H
    Cerebrovasc Dis; 2022; 51(3):373-383. PubMed ID: 34929690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial.
    Anderson CS; Huang Y; Lindley RI; Chen X; Arima H; Chen G; Li Q; Billot L; Delcourt C; Bath PM; Broderick JP; Demchuk AM; Donnan GA; Durham AC; Lavados PM; Lee TH; Levi C; Martins SO; Olavarria VV; Pandian JD; Parsons MW; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Silva F; Song L; Thang NH; Wardlaw JM; Wang JG; Wang X; Woodward M; Chalmers J; Robinson TG;
    Lancet; 2019 Mar; 393(10174):877-888. PubMed ID: 30739745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensive blood pressure control after endovascular thrombectomy for acute ischaemic stroke (ENCHANTED2/MT): a multicentre, open-label, blinded-endpoint, randomised controlled trial.
    Yang P; Song L; Zhang Y; Zhang X; Chen X; Li Y; Sun L; Wan Y; Billot L; Li Q; Ren X; Shen H; Zhang L; Li Z; Xing P; Zhang Y; Zhang P; Hua W; Shen F; Zhou Y; Tian B; Chen W; Han H; Zhang L; Xu C; Li T; Peng Y; Yue X; Chen S; Wen C; Wan S; Yin C; Wei M; Shu H; Nan G; Liu S; Liu W; Cai Y; Sui Y; Chen M; Zhou Y; Zuo Q; Dai D; Zhao R; Li Q; Huang Q; Xu Y; Deng B; Wu T; Lu J; Wang X; Parsons MW; Butcher K; Campbell B; Robinson TG; Goyal M; Dippel D; Roos Y; Majoie C; Wang L; Wang Y; Liu J; Anderson CS;
    Lancet; 2022 Nov; 400(10363):1585-1596. PubMed ID: 36341753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial.
    Hanley DF; Thompson RE; Rosenblum M; Yenokyan G; Lane K; McBee N; Mayo SW; Bistran-Hall AJ; Gandhi D; Mould WA; Ullman N; Ali H; Carhuapoma JR; Kase CS; Lees KR; Dawson J; Wilson A; Betz JF; Sugar EA; Hao Y; Avadhani R; Caron JL; Harrigan MR; Carlson AP; Bulters D; LeDoux D; Huang J; Cobb C; Gupta G; Kitagawa R; Chicoine MR; Patel H; Dodd R; Camarata PJ; Wolfe S; Stadnik A; Money PL; Mitchell P; Sarabia R; Harnof S; Barzo P; Unterberg A; Teitelbaum JS; Wang W; Anderson CS; Mendelow AD; Gregson B; Janis S; Vespa P; Ziai W; Zuccarello M; Awad IA;
    Lancet; 2019 Mar; 393(10175):1021-1032. PubMed ID: 30739747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prehospital transdermal glyceryl trinitrate in patients with presumed acute stroke (MR ASAP): an ambulance-based, multicentre, randomised, open-label, blinded endpoint, phase 3 trial.
    van den Berg SA; Uniken Venema SM; Reinink H; Hofmeijer J; Schonewille WJ; Miedema I; Fransen PSS; O Pruissen DM; Raaijmakers TWM; van Dijk GW; de Leeuw FE; van Vliet JA; Kwa VIH; Kerkhoff H; van 't Net A; Boomars R; Siegers A; Lok T; Caminada K; Esteve Cuevas LM; Visser MC; Zwetsloot CP; Boomsma JMF; Schipper MH; van Eijkelenburg RPJ; Berkhemer OA; Nieboer D; Lingsma HF; Emmer BJ; van Oostenbrugge RJ; van der Lugt A; Roos YBWEM; Majoie CBLM; Dippel DWJ; Nederkoorn PJ; van der Worp HB;
    Lancet Neurol; 2022 Nov; 21(11):971-981. PubMed ID: 36058230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The main Optimal Post rTpa-Iv Monitoring in Ischemic Stroke Trial (OPTIMISTmain): Protocol for a Pragmatic, Stepped Wedge, Cluster Randomized Controlled Trial.
    Ouyang M; Faigle R; Wang X; Johnson B; Summers D; Khatri P; Billot L; Liu H; Malavera A; Muñoz-Venturelli P; González F; Urrutia F; Day D; Song L; Sui Y; Delcourt C; Robinson T; Durham AC; Ebraimo A; Wan Zaidi WA; Jan S; Lindley RI; Urrutia VC; Anderson CS;
    Cerebrovasc Dis; 2024; 53(5):635-642. PubMed ID: 37883934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood pressure control and clinical outcomes in acute intracerebral haemorrhage: a preplanned pooled analysis of individual participant data.
    Moullaali TJ; Wang X; Martin RH; Shipes VB; Robinson TG; Chalmers J; Suarez JI; Qureshi AI; Palesch YY; Anderson CS
    Lancet Neurol; 2019 Sep; 18(9):857-864. PubMed ID: 31397290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tranexamic acid versus placebo in individuals with intracerebral haemorrhage treated within 2 h of symptom onset (STOP-MSU): an international, double-blind, randomised, phase 2 trial.
    Yassi N; Zhao H; Churilov L; Wu TY; Ma H; Nguyen HT; Cheung A; Meretoja A; Mai DT; Kleinig T; Jeng JS; Choi PMC; Duc PD; Brown H; Ranta A; Spratt N; Cloud GC; Wang HK; Grimley R; Mahawish K; Cho DY; Shah D; Nguyen TMP; Sharma G; Yogendrakumar V; Yan B; Harrison EL; Devlin M; Cordato D; Martinez-Majander N; Strbian D; Thijs V; Sanders LM; Anderson D; Parsons MW; Campbell BCV; Donnan GA; Davis SM;
    Lancet Neurol; 2024 Jun; 23(6):577-587. PubMed ID: 38648814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tranexamic acid to improve functional status in adults with spontaneous intracerebral haemorrhage: the TICH-2 RCT.
    Sprigg N; Flaherty K; Appleton JP; Al-Shahi Salman R; Bereczki D; Beridze M; Ciccone A; Collins R; Dineen RA; Duley L; Egea-Guerrero JJ; England TJ; Karlinski M; Krishnan K; Laska AC; Law ZK; Ovesen C; Ozturk S; Pocock SJ; Roberts I; Robinson TG; Roffe C; Peters N; Scutt P; Thanabalan J; Werring D; Whynes D; Woodhouse L; Bath PM
    Health Technol Assess; 2019 Jul; 23(35):1-48. PubMed ID: 31322116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial.
    Baharoglu MI; Cordonnier C; Al-Shahi Salman R; de Gans K; Koopman MM; Brand A; Majoie CB; Beenen LF; Marquering HA; Vermeulen M; Nederkoorn PJ; de Haan RJ; Roos YB;
    Lancet; 2016 Jun; 387(10038):2605-2613. PubMed ID: 27178479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial.
    Selim M; Foster LD; Moy CS; Xi G; Hill MD; Morgenstern LB; Greenberg SM; James ML; Singh V; Clark WM; Norton C; Palesch YY; Yeatts SD;
    Lancet Neurol; 2019 May; 18(5):428-438. PubMed ID: 30898550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apixaban versus no anticoagulation after anticoagulation-associated intracerebral haemorrhage in patients with atrial fibrillation in the Netherlands (APACHE-AF): a randomised, open-label, phase 2 trial.
    Schreuder FHBM; van Nieuwenhuizen KM; Hofmeijer J; Vermeer SE; Kerkhoff H; Zock E; Luijckx GJ; Messchendorp GP; van Tuijl J; Bienfait HP; Booij SJ; van den Wijngaard IR; Remmers MJM; Schreuder AHCML; Dippel DW; Staals J; Brouwers PJAM; Wermer MJH; Coutinho JM; Kwa VIH; van Gelder IC; Schutgens REG; Zweedijk B; Algra A; van Dalen JW; Jaap Kappelle L; Rinkel GJE; van der Worp HB; Klijn CJM;
    Lancet Neurol; 2021 Nov; 20(11):907-916. PubMed ID: 34687635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial.
    Anderson CS; Huang Y; Wang JG; Arima H; Neal B; Peng B; Heeley E; Skulina C; Parsons MW; Kim JS; Tao QL; Li YC; Jiang JD; Tai LW; Zhang JL; Xu E; Cheng Y; Heritier S; Morgenstern LB; Chalmers J;
    Lancet Neurol; 2008 May; 7(5):391-9. PubMed ID: 18396107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood pressure variability and outcome after acute intracerebral haemorrhage: a post-hoc analysis of INTERACT2, a randomised controlled trial.
    Manning L; Hirakawa Y; Arima H; Wang X; Chalmers J; Wang J; Lindley R; Heeley E; Delcourt C; Neal B; Lavados P; Davis SM; Tzourio C; Huang Y; Stapf C; Woodward M; Rothwell PM; Robinson TG; Anderson CS;
    Lancet Neurol; 2014 Apr; 13(4):364-73. PubMed ID: 24530176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of intensive blood pressure lowering after successful endovascular therapy in acute ischaemic stroke (BP-TARGET): a multicentre, open-label, randomised controlled trial.
    Mazighi M; Richard S; Lapergue B; Sibon I; Gory B; Berge J; Consoli A; Labreuche J; Olivot JM; Broderick J; Duhamel A; Touze E; Qureshi AI; Yavchitz A; Escalard S; Desilles JP; Redjem H; Smajda S; Fahed R; Hébert S; Maïer B; Delvoye F; Boursin P; Maacha MB; Obadia M; Sabben C; Blanc R; Savatovsky J; Piotin M;
    Lancet Neurol; 2021 Apr; 20(4):265-274. PubMed ID: 33647246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial.
    Sprigg N; Flaherty K; Appleton JP; Al-Shahi Salman R; Bereczki D; Beridze M; Christensen H; Ciccone A; Collins R; Czlonkowska A; Dineen RA; Duley L; Egea-Guerrero JJ; England TJ; Krishnan K; Laska AC; Law ZK; Ozturk S; Pocock SJ; Roberts I; Robinson TG; Roffe C; Seiffge D; Scutt P; Thanabalan J; Werring D; Whynes D; Bath PM;
    Lancet; 2018 May; 391(10135):2107-2115. PubMed ID: 29778325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.